Classic galactosemia
MONDO:0009258Classic galactosemia is a life-threatening metabolic disease with onset in the neonatal period. Infants usually develop feeding difficulties, lethargy, and severe liver disease.
Also known as: GALT deficiency, classic galactosemia, galactose-1-phosphate uridyltransferase deficiency, galactosemia type 1, classical galactosemia, homozygous duarte-type, Galt deficiency, galactose-1-phosphate uridylyltransferase deficiency, galactosemia
8 clinical trials for this condition and its sub-types, 3 tagged with Classic galactosemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for kids with rare sugar disorder: drug shows promise in trial
Disease control CompletedThis study tested an experimental drug called AT-007 in 47 children aged 2 to 18 with Classic Galactosemia, a rare genetic disorder that makes it hard to break down a sugar called galactose. The goal was to see if the drug could improve behavior, daily living skills, and language…
Phase 2/3 • Sponsor: Applied Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Babble boot camp: could early talk therapy stop speech delays in rare disease?
Prevention CompletedThis study tested a program called Babble Boot Camp for babies with classic galactosemia, a rare condition that often causes speech and language problems. The program started when babies were 2 to 24 months old and involved weekly online coaching for parents from a speech therapi…
Early phase 1 • Sponsor: Arizona State University • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC